Company Profile
Anastasis Biotec Limited
10502511•Private Limited With Share Capital
Get Full Access
29/11/2016
9 years
2
3
72110
low risk
Company Overview
Registration, classification & business activity
Anastasis Biotec Limited (10502511) is a private limited with share capital incorporated on 29/11/2016 (9 years old) and registered in london, NW32BH. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Anastasis’ technology relates to a novel treatment applicable to many cancers.these cancers depend on rogue cells multiplying uncontrollably caused by dna abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells. when there are mutations in these pat...
Financial Overview
£167.4K
£83.1K
£84.3K
£78.3K
Key Metrics
3
Employees
2
Directors
97
Shareholders
2
Patents
Board of Directors
Innovate Grants
This company received a grant of £330820.0 for Developing A Specific Notch Pathway Inhibitor As A Prostate Cancer Stem Cell Therapeutic. The project started on 01/05/2019 and ended on 31/10/2021.
This company received a grant of £40280.0 for Developing A Specific Notch Pathway Inhibitor As A Prostate Cancer Stem Cell Therapeutic (Continuity). The project started on 01/06/2020 and ended on 30/11/2020.
Risk Assessment
low risk
International Score
Future Factor
good
Performance Rating